S
Sang-Kyu Lee
Researcher at Hallym University
Publications - 45
Citations - 839
Sang-Kyu Lee is an academic researcher from Hallym University. The author has contributed to research in topics: Beck Depression Inventory & Depression (differential diagnoses). The author has an hindex of 12, co-authored 42 publications receiving 680 citations.
Papers
More filters
Journal ArticleDOI
Association of depression with malnutrition in chronic hemodialysis patients
Ja-Ryong Koo,Jong-Woo Yoon,Seong-Gyun Kim,Young-Ki Lee,Kook-Hwan Oh,Gheun-Ho Kim,Hyung-Jik Kim,Dong-Wan Chae,Jung-Woo Noh,Sang-Kyu Lee,Bong-Ki Son +10 more
TL;DR: In patients on chronic hemodialysis therapy, depression is related closely to nutritional status and could be an independent risk factor for malnutrition.
Journal ArticleDOI
Treatment of Depression and Effect of Antidepression Treatment on Nutritional Status in Chronic Hemodialysis Patients
Ja-Ryong Koo,Jong-Yoo Yoon,Min-Ha Joo,Hyung Seok Lee,Jieun Oh,Seong-Gyun Kim,Jangwon Seo,Young-Ki Lee,Hyung-Jik Kim,Jung-Woo Noh,Sang-Kyu Lee,Bong-Ki Son +11 more
TL;DR: It is suggested that antidepressant medication with supportive psychotherapy can successfully treat depression and improve nutritional status in chronic hemodialysis patients with depression.
Journal ArticleDOI
Development of the Internet addiction scale based on the Internet Gaming Disorder criteria suggested in DSM-5.
TL;DR: A standardized self-diagnostic Internet addiction scale based on the diagnosis criteria for Internet Gaming Disorder in the Diagnostic and Statistical Manual of Mental Disorder, 5th edition (DSM-5) was developed and validated, and some factors were very highly correlated.
Journal ArticleDOI
The Effects of Antidepressant Treatment on Serum Cytokines and Nutritional Status in Hemodialysis Patients
TL;DR: It is suggested that antidepressant treatment improve depressive symptoms and may affect immunological functions and nutritional status in chronic hemodialysis patients with depression.
Journal ArticleDOI
Comparative Efficacy and Safety of Long-acting Injectable and Oral Second-generation Antipsychotics for the Treatment of Schizophrenia: A Systematic Review and Meta-analysis
Seon Cheol Park,Mi Young Choi,Jina Choi,Eun Jung Park,Ha Jin Tchoe,Jae Kyung Suh,Younghoon Kim,Seunghee Won,Young Chul Chung,Kyung Yeol Bae,Sang-Kyu Lee,Chan Mi Park,Seung Hwan Lee +12 more
TL;DR: There is moderate to high level of evidence suggesting that in the treatment of schizophrenia, LAI SGAs have higher efficacy and are associated with higher rates of extrapyramidal syndrome and prolactin-related symptoms.